IL208947A0 - Ophthalmic devices for the controlled release of active agents - Google Patents
Ophthalmic devices for the controlled release of active agentsInfo
- Publication number
- IL208947A0 IL208947A0 IL208947A IL20894710A IL208947A0 IL 208947 A0 IL208947 A0 IL 208947A0 IL 208947 A IL208947 A IL 208947A IL 20894710 A IL20894710 A IL 20894710A IL 208947 A0 IL208947 A0 IL 208947A0
- Authority
- IL
- Israel
- Prior art keywords
- active agents
- controlled release
- ophthalmic devices
- ophthalmic
- devices
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5108508P | 2008-05-07 | 2008-05-07 | |
PCT/US2009/043139 WO2009137673A1 (en) | 2008-05-07 | 2009-05-07 | Ophthalmic devices for the controlled release of active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IL208947A0 true IL208947A0 (en) | 2011-01-31 |
Family
ID=40758669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL208947A IL208947A0 (en) | 2008-05-07 | 2010-10-26 | Ophthalmic devices for the controlled release of active agents |
Country Status (16)
Country | Link |
---|---|
US (2) | US20090306608A1 (en) |
EP (1) | EP2285321B1 (en) |
JP (1) | JP2011522575A (en) |
KR (1) | KR20110015587A (en) |
CN (1) | CN102014817B (en) |
AR (1) | AR071691A1 (en) |
AU (1) | AU2009244191B2 (en) |
BR (1) | BRPI0912252A2 (en) |
CA (1) | CA2723361A1 (en) |
ES (1) | ES2408163T3 (en) |
HK (1) | HK1153636A1 (en) |
IL (1) | IL208947A0 (en) |
PL (1) | PL2285321T3 (en) |
RU (1) | RU2010150095A (en) |
TW (1) | TWI542338B (en) |
WO (1) | WO2009137673A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
WO2009105178A2 (en) * | 2008-02-18 | 2009-08-27 | Qlt Plug Delivery, Inc. | Lacrimal implants and related methods |
US8894602B2 (en) | 2010-09-17 | 2014-11-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs with directional release |
TW201043211A (en) * | 2009-03-31 | 2010-12-16 | Johnson & Johnson Vision Care Inc | Punctal plugs |
TWI495459B (en) * | 2009-03-31 | 2015-08-11 | Johnson & Johnson Vision Care | Punctal plugs |
US9421127B2 (en) | 2009-03-31 | 2016-08-23 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
CA2979355C (en) | 2009-05-18 | 2023-02-21 | Dose Medical Corporation | Drug eluting ocular implant |
US10206813B2 (en) * | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US8808257B2 (en) | 2009-08-31 | 2014-08-19 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for pulsatile release of medicaments from a punctal plug |
US9259352B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US9259351B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US20110251568A1 (en) * | 2010-04-08 | 2011-10-13 | Beeley Nathan R F | Punctal plugs for controlled release of therapeutic agents |
US20110301555A1 (en) * | 2010-06-03 | 2011-12-08 | Gonzalez-Zugasti Javier P | Porous matrix drug core for lacrimal insert device |
US20110311606A1 (en) * | 2010-06-18 | 2011-12-22 | Coldren Bret A | Punctal plugs with continuous or pulsatile drug release mechanism |
US8821457B2 (en) * | 2010-09-08 | 2014-09-02 | Johnson & Johnson Vision Care, Inc. | Punctal plug containing drug formulation |
US20120157938A1 (en) | 2010-12-16 | 2012-06-21 | Tokarski Jason M | Punctal plug with drug core retention features |
US20120215184A1 (en) * | 2011-02-18 | 2012-08-23 | Valeant International (Barbados) Srl | Cylindrical ocular inserts |
US9301874B2 (en) | 2011-05-06 | 2016-04-05 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for controlled release of therapeutic agents |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US20130018360A1 (en) * | 2011-07-13 | 2013-01-17 | Marissa Dockendorf | Method for delivering ophthalmic drugs |
US8911227B2 (en) * | 2012-01-11 | 2014-12-16 | Johnson & Johnson Vision Care, Inc. | Device for injection molding silicone rubber |
EP2830553B1 (en) | 2012-03-26 | 2017-12-27 | Glaukos Corporation | Apparatus for delivering multiple ocular implants |
US10507245B2 (en) | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
WO2014031676A1 (en) * | 2012-08-20 | 2014-02-27 | O-Ray Pharma, Inc. | Process for manufacturing drug delivery formulations |
CN112932781A (en) | 2013-01-15 | 2021-06-11 | 科罗拉多州立大学董事会, 公司实体 | Lacrimal system drug delivery device |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US20140336619A1 (en) * | 2013-05-13 | 2014-11-13 | Abbott Cardiovascular Systems Inc. | Ophthalmic shunt and method |
DK3131613T3 (en) * | 2014-04-16 | 2023-08-28 | Hollister Inc | MOLDED CATHETER TIP |
EP3148491B1 (en) | 2014-05-29 | 2020-07-01 | Glaukos Corporation | Implants with controlled drug delivery features and manufacturing method for said implants |
KR20180034541A (en) * | 2015-07-22 | 2018-04-04 | 인셉트, 엘엘씨 | Coated tear point plug |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
WO2017053885A1 (en) * | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
CA3006042A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal system for drug delivery |
EP3442479A1 (en) | 2016-04-20 | 2019-02-20 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
AU2017268379A1 (en) | 2016-05-20 | 2018-12-06 | The Regents Of The University Of Colorado, A Body Corporate | Lacrimal drug delivery device |
AU2018305160A1 (en) | 2017-07-25 | 2020-01-30 | PK Med SAS | Process for preparing a drug delivery composition |
CA3209420A1 (en) | 2021-02-24 | 2022-09-01 | Peter Jarrett | Intracanalicular depot inserter device |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
DK469989D0 (en) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | PHARMACEUTICAL PREPARATION |
DE4431653C2 (en) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Coated tablet for the controlled release of active substances, a process for their preparation and their use |
US6020445A (en) | 1997-10-09 | 2000-02-01 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
US5962548A (en) | 1998-03-02 | 1999-10-05 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
US6367929B1 (en) | 1998-03-02 | 2002-04-09 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
US6822016B2 (en) | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US6099852A (en) | 1998-09-23 | 2000-08-08 | Johnson & Johnson Vision Products, Inc. | Wettable silicone-based lenses |
US6565535B2 (en) * | 2000-06-16 | 2003-05-20 | Nardo Zaias | Medical infusion and aspiration system |
GB0117618D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
US6921390B2 (en) * | 2001-07-23 | 2005-07-26 | Boston Scientific Scimed, Inc. | Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface |
US20080038317A1 (en) * | 2004-09-10 | 2008-02-14 | Chin-Ming Chang | Therapeutic Lacrimal Canalicular Inserts And Related Methods |
CN2897206Y (en) * | 2006-01-12 | 2007-05-09 | 温州医学院眼视光研究院 | Convienent sclera plug |
US20080045911A1 (en) * | 2006-06-21 | 2008-02-21 | Borgia Maureen J | Punctal plugs for the delivery of active agents |
CN101505695A (en) * | 2006-06-21 | 2009-08-12 | 庄臣及庄臣视力保护公司 | Punctal plugs for the delivery of active agents |
SG138567A1 (en) * | 2006-06-21 | 2008-01-28 | Johnson & Johnson Vision Care | Punctal plugs for the delivery of active agents |
-
2009
- 2009-05-06 TW TW098114932A patent/TWI542338B/en active
- 2009-05-07 CA CA2723361A patent/CA2723361A1/en not_active Abandoned
- 2009-05-07 ES ES09743659T patent/ES2408163T3/en active Active
- 2009-05-07 WO PCT/US2009/043139 patent/WO2009137673A1/en active Application Filing
- 2009-05-07 AR ARP090101653A patent/AR071691A1/en unknown
- 2009-05-07 KR KR1020107027100A patent/KR20110015587A/en not_active Application Discontinuation
- 2009-05-07 JP JP2011508664A patent/JP2011522575A/en active Pending
- 2009-05-07 EP EP09743659A patent/EP2285321B1/en active Active
- 2009-05-07 CN CN200980116887.8A patent/CN102014817B/en active Active
- 2009-05-07 PL PL09743659T patent/PL2285321T3/en unknown
- 2009-05-07 AU AU2009244191A patent/AU2009244191B2/en active Active
- 2009-05-07 RU RU2010150095/14A patent/RU2010150095A/en unknown
- 2009-05-07 BR BRPI0912252A patent/BRPI0912252A2/en not_active Application Discontinuation
- 2009-05-07 US US12/437,163 patent/US20090306608A1/en not_active Abandoned
-
2010
- 2010-05-13 US US12/779,238 patent/US8377042B2/en active Active
- 2010-10-26 IL IL208947A patent/IL208947A0/en unknown
-
2011
- 2011-07-29 HK HK11107888.7A patent/HK1153636A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2285321B1 (en) | 2013-04-03 |
BRPI0912252A2 (en) | 2017-06-13 |
CN102014817B (en) | 2014-06-04 |
ES2408163T3 (en) | 2013-06-18 |
EP2285321A1 (en) | 2011-02-23 |
TWI542338B (en) | 2016-07-21 |
US20090306608A1 (en) | 2009-12-10 |
RU2010150095A (en) | 2012-06-20 |
AR071691A1 (en) | 2010-07-07 |
US20110022007A1 (en) | 2011-01-27 |
AU2009244191A1 (en) | 2009-11-12 |
CA2723361A1 (en) | 2009-11-12 |
CN102014817A (en) | 2011-04-13 |
US8377042B2 (en) | 2013-02-19 |
PL2285321T3 (en) | 2013-09-30 |
HK1153636A1 (en) | 2012-04-05 |
JP2011522575A (en) | 2011-08-04 |
WO2009137673A1 (en) | 2009-11-12 |
AU2009244191B2 (en) | 2015-05-14 |
TW201006452A (en) | 2010-02-16 |
KR20110015587A (en) | 2011-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL208947A0 (en) | Ophthalmic devices for the controlled release of active agents | |
HK1258967A1 (en) | Ophthalmic devices for delivery of hydrophobic comfort agents | |
HRP20181608T1 (en) | Use of pde7 inhibitors for the treatment of movement disorders | |
BRPI0818874A2 (en) | Active Agents Release | |
GB0811304D0 (en) | Therapeutic agents | |
EP2291155A4 (en) | Ophthalmic surgical device for capsulotomy | |
IL208481A0 (en) | Controlled release of active agents from oleosomes | |
GB0819593D0 (en) | Therapeutic agents | |
IL193611A0 (en) | Dividable galenical form allowing modified release of the active ingredient | |
EP2139475A4 (en) | The use of pde7 inhibitors for the treatment of movement disorders | |
EP2331629A4 (en) | Starch-based microparticles for the release of agents disposed therein | |
GB0821693D0 (en) | Therapeutic agents | |
IL201465A0 (en) | Self-precipitating pharmaceutical formulations for the modified release of active principle | |
HK1207830A1 (en) | Dressing having the controlled release of active agents | |
GB0812309D0 (en) | Therapeutic agents | |
GB0805818D0 (en) | Therapeutic agents | |
GB0801080D0 (en) | Therapeutic agents | |
GB0801081D0 (en) | Therapeutic agents | |
ZA201304511B (en) | An implant for the controlled release of pharmaceutically active agents | |
HUE037915T2 (en) | Pharmaceutical forms for the release of active compounds | |
ZA200901118B (en) | Formulations for the controlled release of agrochemical active agents | |
IL202506A0 (en) | Neramexane for the treatment of nystagmus | |
PL2219611T3 (en) | Pharmaceutical forms for the release of active compounds | |
EP2155171A4 (en) | Osmotic form for controlled release of active principles | |
GB0811715D0 (en) | Therapeutic agents |